Wockhardt Limited has announced that it has received tentative approval from the US Food and Drug Administration for marketing market Memantine tablets
Wockhardt Limited has announced that it has received tentative approval from the US Food and Drug Administration for marketing market Memantine tablets in the strength of 5 mg and 10 mg. Memantine is used in the treatment of Alzheimer`s disease.
The drug works by suppressing N-Methyl-D-Aspartate (NMDA) receptors, which are thought to be responsible for the deterioration of cholinergic cells in the brain.
Alzheimer’s disease - Causes, Symptoms, Diagnosis, Stages, Types, Prevention, Prognosis & Treatment
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Source-Medindia
RAS
Dyslexia - Causes, Symptoms, Diagnosis, Treatment
Dyslexia is a reading disability that occurs when the brain does not properly recognize and process certain symbols.
Dyslexia is a reading disability that occurs when the brain does not properly recognize and process certain symbols.
About Schizophrenia
Schizophrenia is a mental disorder characterized by symptoms of thought, behavior and social problems.
Schizophrenia is a mental disorder characterized by symptoms of thought, behavior and social problems.
